tiprankstipranks
XORTX Therapeutics Inc (XRTX)
NASDAQ:XRTX
US Market
XRTX
XORTX Therapeutics Inc
RESEARCH TOOLSreports
Want to see XRTX full AI Analyst Report?

XORTX Therapeutics Inc (XRTX) Income Statement

83 Followers

XORTX Therapeutics Inc Income Statement

Last quarter (Q4 2025), XORTX Therapeutics Inc's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, XORTX Therapeutics Inc's net income was C$-823.32K. See XORTX Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Mar 23Mar 22
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -156.66KC$ -160.66K-C$ -75.27KC$ -17.88K
Operating Expenses
C$ 4.39MC$ 5.48MC$ 4.81MC$ 9.86MC$ 2.90M
Depreciation and Amortization
C$ 156.66KC$ 160.66KC$ 188.54KC$ 75.27KC$ 17.88K
EBITDA
C$ -4.39MC$ -4.38M-C$ -9.41M-
Operating Income
C$ -4.55MC$ -5.64M-C$ -12.43M-
Other Income/Expenses
C$ 837.97KC$ 1.10MC$ 1.95MC$ 2.95MC$ 1.25M
Pretax Income
C$ -3.71MC$ -4.54M-C$ -9.49MC$ -1.65M
Net Income
C$ -3.71MC$ -4.54M--C$ -1.65M
Per Share Metrics
Basic EPS
C$ -19.50C$ -39.50C$ -36.00C$ -118.00C$ -30.00
Diluted EPS
C$ -19.50C$ -39.50C$ -36.00C$ -118.00C$ -30.00
Weighted Average Shares Outstanding
 189.38K 115.14K 79.27K 59.20K 43.77K
Weighted Average Shares Outstanding (Diluted)
 189.38K 115.14K 79.27K 59.20K 43.77K
Currency in CAD

XORTX Therapeutics Inc Earnings and Revenue History